Advance Authorization conditionality: Erythromycin thiocyanate exempt for manufacture and export of erythromycin salts; other uses follow policy conditions. Import of Erythromycin Thiocyanate for manufacture and export of Erythromycin Salts under the Advance Authorisation Scheme is exempt from the additional conditionalities of Policy Circulars No.9 and No.15 and is subject only to normal Advance Authorisation conditions; imports for veterinary medicinal use or for manufacture of any other drug under Advance Authorisation remain subject to the Policy Circular conditionalities in addition to normal Advance Authorisation conditions.